Browse by Journal Title

2023

Daratumumab as a novel treatment option in refractory ITP.
Vernava, I. and Schmitt, C.A.
Blood Cells Molecules and Diseases 99 : 102724. March 2023

2005

Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
Holdhoff, M. and Kreuzer, K.A. and Appelt, C. and Scholz, R. and Na, I.K. and Hildebrandt, B. and Riess, H. and Jordan, A. and Schmidt, C.A. and Van Etten, R.A. and Doerken, B. and LeCoutre, P.
Blood Cells Molecules and Diseases 34 (2): 181-185. 1 March 2005

2002

Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.
le Coutre, P. and Kreuzer, K.A. and Na, I.K. and Lupberger, J. and Holdhoff, M. and Appelt, C. and Schwarz, M. and Mueller, C. and Gambacorti-Passerini, C. and Platzbecker, U. and Bonnet, R. and Ehninger, G. and Schmidt, C.A.
Blood Cells Molecules and Diseases 28 (1): 75-85. January 2002

2001

Bcl-2 mediates chemoresistance in matched pairs of primary Emu-myc lymphomas in vivo.
Schmitt, C.A. and Lowe, S.W.
Blood Cells Molecules and Diseases 27 (1): 206-216. January 2001